CN Stock MarketDetailed Quotes

301201 Chengda Pharmaceuticals

Watchlist
  • 17.49
  • -0.34-1.91%
Market Closed Sep 13 15:00 CST
2.71BMarket Cap31.18P/E (TTM)

Chengda Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-1.55%164.01M
-1.28%100.89M
0.69%414.3M
-14.85%260.26M
-23.31%166.59M
-5.91%102.2M
-1.03%411.46M
5.45%305.65M
11.31%217.23M
23.54%108.62M
Operating revenue
-1.55%164.01M
-1.28%100.89M
0.69%414.3M
-14.85%260.26M
-23.31%166.59M
-5.91%102.2M
-1.03%411.46M
5.45%305.65M
11.31%217.23M
23.54%108.62M
Other operating revenue
89.80%852.87K
----
727.26%1.03M
----
--449.36K
----
-10.70%124K
----
--0
----
Total operating cost
9.47%164.25M
0.46%88.95M
7.88%351.49M
-2.84%224.67M
-4.81%150.04M
11.52%88.54M
7.24%325.83M
9.22%231.23M
13.32%157.62M
25.48%79.4M
Operating cost
-2.79%99.64M
-8.02%59.73M
10.61%236.62M
1.24%152.7M
-4.00%102.5M
23.53%64.94M
2.86%213.93M
0.57%150.84M
7.31%106.77M
18.41%52.57M
Operating tax surcharges
116.63%2.17M
-13.21%423.12K
-13.98%3.57M
-25.59%1.65M
-8.27%1M
129.85%487.51K
67.98%4.15M
83.56%2.21M
-6.94%1.09M
-50.33%212.1K
Operating expense
30.90%2.18M
-7.09%936.91K
-40.85%3.2M
-29.93%2.59M
-38.53%1.66M
-39.18%1.01M
19.77%5.4M
29.86%3.69M
62.88%2.7M
119.58%1.66M
Administration expense
20.40%44.12M
10.12%18.97M
0.05%88.36M
-11.71%57.9M
-11.15%36.65M
-15.00%17.22M
28.15%88.31M
45.98%65.58M
46.31%41.25M
54.93%20.26M
Financial expense
-102.29%-2.97M
-787.18%-889.35K
-42.76%-7.72M
-6.01%-6.05M
60.84%-1.47M
145.92%129.42K
-297.80%-5.41M
-651.71%-5.71M
-515.65%-3.75M
-239.92%-281.86K
-Interest expense (Financial expense)
--12.36K
-37.21%10.06K
----
----
----
-91.86%16.03K
-85.81%198.48K
-75.34%196.82K
--196.82K
56.18%196.82K
-Interest Income (Financial expense)
-1,047.83%-1.21M
-1,386.70%-776.61K
-545.42%-6.37M
-334.61%-4.45M
89.57%-105.63K
94.01%-52.24K
-284.99%-986.61K
-345.66%-1.02M
---1.01M
-1,048.06%-871.58K
Research and development
97.03%19.11M
105.63%9.78M
41.26%27.46M
8.68%15.9M
1.57%9.7M
-4.46%4.76M
12.89%19.44M
24.80%14.63M
24.61%9.55M
12.73%4.98M
Credit Impairment Loss
110.39%4.45M
711.93%1.03M
-438.25%-6.03M
2,529.50%2.29M
5,353.89%2.11M
131.61%126.74K
22.10%-1.12M
243.75%87K
-150.16%-40.22K
21.60%-400.92K
Asset Impairment Loss
20.27%-1.12M
-130.77%-818.66K
141.02%3.66M
444.17%1.71M
-6,286.04%-1.4M
1,997.57%2.66M
-688.20%-8.91M
-53.80%-495.93K
55.07%-21.95K
-340.96%-140.19K
Other net revenue
42.89%27.83M
7.47%11.04M
16.52%44.99M
3.88%36.85M
-8.78%19.48M
500.52%10.27M
595.82%38.61M
636.14%35.47M
346.83%21.35M
1,368.62%1.71M
Fair value change income
--3.66M
----
----
----
----
----
--393.37K
--18.26M
--8.98M
----
Invest income
14.12%18.83M
33.83%9.34M
6.51%41.82M
219.83%29.43M
217.26%16.5M
735.17%6.98M
--39.27M
--9.2M
--5.2M
--835.34K
Net open hedge income
----
----
----
----
----
----
----
----
--0
----
Exchange income
----
----
----
----
----
----
----
----
--0
----
Asset deal income
3,863.35%129.45K
2,712.87%91.87K
100.61%3.27K
100.61%3.27K
100.61%3.27K
100.61%3.27K
-2,487.86%-531.11K
-2,522.70%-538.26K
-2,522.70%-538.26K
-2,522.70%-538.26K
Other revenue
-17.03%1.87M
177.00%1.4M
-41.83%5.53M
-61.88%3.41M
-70.95%2.26M
-74.12%505.91K
16.91%9.51M
71.51%8.96M
62.99%7.77M
355.79%1.95M
Operating profit
-23.41%27.59M
-3.95%22.98M
-13.24%107.8M
-34.09%72.43M
-55.51%36.02M
-22.64%23.93M
5.79%124.25M
32.45%109.88M
33.07%80.96M
26.20%30.93M
Add:Non operating Income
-79.31%6.16K
-83.87%2.39K
92.76%99.43K
131.58%61.24K
155.85%29.79K
121.64%14.79K
-89.01%51.58K
-29.48%26.44K
-61.11%11.64K
-51.16%6.67K
Less:Non operating expense
-56.04%1.34M
11.82%948.95K
-12.90%3.65M
88.55%3.14M
209.50%3.04M
808.78%848.61K
59.48%4.19M
-19.15%1.67M
2.41%983.4K
--93.38K
Total profit
-20.45%26.26M
-4.58%22.04M
-13.20%104.25M
-35.93%69.35M
-58.74%33.01M
-25.12%23.1M
4.18%120.11M
33.73%108.24M
33.51%79.99M
25.78%30.84M
Less:Income tax cost
-70.80%1.05M
-4.74%3.31M
-3.55%13.15M
-50.33%8.07M
-75.94%3.59M
-24.97%3.48M
-9.19%13.63M
53.81%16.25M
65.16%14.93M
27.77%4.63M
Net profit
-14.30%25.21M
-4.56%18.73M
-14.44%91.1M
-33.39%61.28M
-54.79%29.41M
-25.15%19.62M
6.19%106.48M
30.72%91.99M
27.89%65.06M
25.43%26.21M
Net profit from continuing operation
-14.30%25.21M
-4.56%18.73M
-14.44%91.1M
-33.39%61.28M
-54.79%29.41M
-25.15%19.62M
6.19%106.48M
30.72%91.99M
27.89%65.06M
25.43%26.21M
Less:Minority Profit
-47.20%33.03K
431.38%81.78K
1,806.32%121.7K
259.26%90.96K
288.36%62.56K
-46.54%-24.68K
95.59%-7.13K
56.92%-57.12K
49.13%-33.21K
56.68%-16.84K
Net profit of parent company owners
-14.23%25.17M
-5.09%18.64M
-14.56%90.98M
-33.53%61.18M
-54.91%29.35M
-25.10%19.64M
6.02%106.48M
30.55%92.05M
27.79%65.09M
25.28%26.23M
Earning per share
Basic earning per share
-13.02%0.165
-4.33%0.1215
-16.33%0.5881
-35.37%0.3955
-72.99%0.1897
-57.08%0.127
-49.25%0.7029
-37.06%0.6119
0.01%0.7024
2.49%0.2959
Diluted earning per share
-13.02%0.165
-4.33%0.1215
-16.33%0.5881
-35.37%0.3955
-72.99%0.1897
-57.08%0.127
-49.25%0.7029
-37.06%0.6119
0.01%0.7024
2.49%0.2959
Other composite income
Total composite income
-14.30%25.21M
-4.56%18.73M
-14.44%91.1M
-33.39%61.28M
-54.79%29.41M
-25.15%19.62M
6.19%106.48M
30.72%91.99M
27.89%65.06M
25.43%26.21M
Total composite income of parent company owners
-14.23%25.17M
-5.09%18.64M
-14.56%90.98M
-33.53%61.18M
-54.91%29.35M
-25.10%19.64M
6.02%106.48M
30.55%92.05M
27.79%65.09M
25.28%26.23M
Total composite income of minority owners
-47.20%33.03K
431.38%81.78K
1,806.32%121.7K
259.26%90.96K
288.36%62.56K
-46.54%-24.68K
95.59%-7.13K
56.92%-57.12K
49.13%-33.21K
56.68%-16.84K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Zhonghua Certified Public Accountants (Special General Partnership)
--
--
--
Zhonghua Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -1.55%164.01M-1.28%100.89M0.69%414.3M-14.85%260.26M-23.31%166.59M-5.91%102.2M-1.03%411.46M5.45%305.65M11.31%217.23M23.54%108.62M
Operating revenue -1.55%164.01M-1.28%100.89M0.69%414.3M-14.85%260.26M-23.31%166.59M-5.91%102.2M-1.03%411.46M5.45%305.65M11.31%217.23M23.54%108.62M
Other operating revenue 89.80%852.87K----727.26%1.03M------449.36K-----10.70%124K------0----
Total operating cost 9.47%164.25M0.46%88.95M7.88%351.49M-2.84%224.67M-4.81%150.04M11.52%88.54M7.24%325.83M9.22%231.23M13.32%157.62M25.48%79.4M
Operating cost -2.79%99.64M-8.02%59.73M10.61%236.62M1.24%152.7M-4.00%102.5M23.53%64.94M2.86%213.93M0.57%150.84M7.31%106.77M18.41%52.57M
Operating tax surcharges 116.63%2.17M-13.21%423.12K-13.98%3.57M-25.59%1.65M-8.27%1M129.85%487.51K67.98%4.15M83.56%2.21M-6.94%1.09M-50.33%212.1K
Operating expense 30.90%2.18M-7.09%936.91K-40.85%3.2M-29.93%2.59M-38.53%1.66M-39.18%1.01M19.77%5.4M29.86%3.69M62.88%2.7M119.58%1.66M
Administration expense 20.40%44.12M10.12%18.97M0.05%88.36M-11.71%57.9M-11.15%36.65M-15.00%17.22M28.15%88.31M45.98%65.58M46.31%41.25M54.93%20.26M
Financial expense -102.29%-2.97M-787.18%-889.35K-42.76%-7.72M-6.01%-6.05M60.84%-1.47M145.92%129.42K-297.80%-5.41M-651.71%-5.71M-515.65%-3.75M-239.92%-281.86K
-Interest expense (Financial expense) --12.36K-37.21%10.06K-------------91.86%16.03K-85.81%198.48K-75.34%196.82K--196.82K56.18%196.82K
-Interest Income (Financial expense) -1,047.83%-1.21M-1,386.70%-776.61K-545.42%-6.37M-334.61%-4.45M89.57%-105.63K94.01%-52.24K-284.99%-986.61K-345.66%-1.02M---1.01M-1,048.06%-871.58K
Research and development 97.03%19.11M105.63%9.78M41.26%27.46M8.68%15.9M1.57%9.7M-4.46%4.76M12.89%19.44M24.80%14.63M24.61%9.55M12.73%4.98M
Credit Impairment Loss 110.39%4.45M711.93%1.03M-438.25%-6.03M2,529.50%2.29M5,353.89%2.11M131.61%126.74K22.10%-1.12M243.75%87K-150.16%-40.22K21.60%-400.92K
Asset Impairment Loss 20.27%-1.12M-130.77%-818.66K141.02%3.66M444.17%1.71M-6,286.04%-1.4M1,997.57%2.66M-688.20%-8.91M-53.80%-495.93K55.07%-21.95K-340.96%-140.19K
Other net revenue 42.89%27.83M7.47%11.04M16.52%44.99M3.88%36.85M-8.78%19.48M500.52%10.27M595.82%38.61M636.14%35.47M346.83%21.35M1,368.62%1.71M
Fair value change income --3.66M----------------------393.37K--18.26M--8.98M----
Invest income 14.12%18.83M33.83%9.34M6.51%41.82M219.83%29.43M217.26%16.5M735.17%6.98M--39.27M--9.2M--5.2M--835.34K
Net open hedge income ----------------------------------0----
Exchange income ----------------------------------0----
Asset deal income 3,863.35%129.45K2,712.87%91.87K100.61%3.27K100.61%3.27K100.61%3.27K100.61%3.27K-2,487.86%-531.11K-2,522.70%-538.26K-2,522.70%-538.26K-2,522.70%-538.26K
Other revenue -17.03%1.87M177.00%1.4M-41.83%5.53M-61.88%3.41M-70.95%2.26M-74.12%505.91K16.91%9.51M71.51%8.96M62.99%7.77M355.79%1.95M
Operating profit -23.41%27.59M-3.95%22.98M-13.24%107.8M-34.09%72.43M-55.51%36.02M-22.64%23.93M5.79%124.25M32.45%109.88M33.07%80.96M26.20%30.93M
Add:Non operating Income -79.31%6.16K-83.87%2.39K92.76%99.43K131.58%61.24K155.85%29.79K121.64%14.79K-89.01%51.58K-29.48%26.44K-61.11%11.64K-51.16%6.67K
Less:Non operating expense -56.04%1.34M11.82%948.95K-12.90%3.65M88.55%3.14M209.50%3.04M808.78%848.61K59.48%4.19M-19.15%1.67M2.41%983.4K--93.38K
Total profit -20.45%26.26M-4.58%22.04M-13.20%104.25M-35.93%69.35M-58.74%33.01M-25.12%23.1M4.18%120.11M33.73%108.24M33.51%79.99M25.78%30.84M
Less:Income tax cost -70.80%1.05M-4.74%3.31M-3.55%13.15M-50.33%8.07M-75.94%3.59M-24.97%3.48M-9.19%13.63M53.81%16.25M65.16%14.93M27.77%4.63M
Net profit -14.30%25.21M-4.56%18.73M-14.44%91.1M-33.39%61.28M-54.79%29.41M-25.15%19.62M6.19%106.48M30.72%91.99M27.89%65.06M25.43%26.21M
Net profit from continuing operation -14.30%25.21M-4.56%18.73M-14.44%91.1M-33.39%61.28M-54.79%29.41M-25.15%19.62M6.19%106.48M30.72%91.99M27.89%65.06M25.43%26.21M
Less:Minority Profit -47.20%33.03K431.38%81.78K1,806.32%121.7K259.26%90.96K288.36%62.56K-46.54%-24.68K95.59%-7.13K56.92%-57.12K49.13%-33.21K56.68%-16.84K
Net profit of parent company owners -14.23%25.17M-5.09%18.64M-14.56%90.98M-33.53%61.18M-54.91%29.35M-25.10%19.64M6.02%106.48M30.55%92.05M27.79%65.09M25.28%26.23M
Earning per share
Basic earning per share -13.02%0.165-4.33%0.1215-16.33%0.5881-35.37%0.3955-72.99%0.1897-57.08%0.127-49.25%0.7029-37.06%0.61190.01%0.70242.49%0.2959
Diluted earning per share -13.02%0.165-4.33%0.1215-16.33%0.5881-35.37%0.3955-72.99%0.1897-57.08%0.127-49.25%0.7029-37.06%0.61190.01%0.70242.49%0.2959
Other composite income
Total composite income -14.30%25.21M-4.56%18.73M-14.44%91.1M-33.39%61.28M-54.79%29.41M-25.15%19.62M6.19%106.48M30.72%91.99M27.89%65.06M25.43%26.21M
Total composite income of parent company owners -14.23%25.17M-5.09%18.64M-14.56%90.98M-33.53%61.18M-54.91%29.35M-25.10%19.64M6.02%106.48M30.55%92.05M27.79%65.09M25.28%26.23M
Total composite income of minority owners -47.20%33.03K431.38%81.78K1,806.32%121.7K259.26%90.96K288.36%62.56K-46.54%-24.68K95.59%-7.13K56.92%-57.12K49.13%-33.21K56.68%-16.84K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Zhonghua Certified Public Accountants (Special General Partnership)------Zhonghua Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data